ArticleDiabetologia2013
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
M A Nauck et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it